China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) has reportedly entered into a strategic cooperation agreement with Nigeria-based Fidson Healthcare plc. The partnership aims to facilitate the import of innovative HIV/AIDS therapies into Nigeria, a country with a significant population of 1.9 million HIV-infected individuals.
Multi-Layered Collaboration on HIV/AIDS Treatments
The agreement outlines a multi-level collaboration between the two companies, encompassing project development and market expansion. The cooperation will span across manufacturing, promotion, sales, and clinical research for both existing and pipeline products. The specific terms of the agreement have not been disclosed to the public.- Flcube.com